as on January 21, 2026 at 4:01 pm IST
Day's Low
0.51%
Downside
52 Week's Low
52 Week's High
13.59%
Downside
109.90%
Upside
as on January 21, 2026 at 4:01 pm IST
Market Cap
₹13.87 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
0Return on capital employed (ROCE)
0Beta (LTM)
0.95
P/B Ratio
0.82
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
0EPS (TTM)
-21.06
Sector
Healthcare
Book Value
16.51
Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Vanta Bioscience with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 13.87 | -16.88% | 0.93 | -14 | 1 | |
| NA | 64.75 | 2.46% | 0.50 | 2 | 21 | |
| NA | 346.82 | 9.63% | 0.67 | 8 | 106 | |
| NA | 175.50 | -6.96% | 0.00 | 3 | 22 | |
| NA | 23.10 | -16.75% | 0.00 | -3 | 13 |
Get share price movements and forecasts by analysts on Vanta Bioscience.
Source: S&P Global Market Intelligence
Search interest for Vanta Bioscience Ltd Stock has decreased by -28% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Vanta Bioscience.
Vanta Bioscience Ltd’s net profit fell -2042.86% since last year same period to ₹-1.36Cr in the Q4 2022-2023. On a quarterly growth basis, Vanta Bioscience Ltd has generated 46.88% jump in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 72.81% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 1 year, Take Solutions Ltd has given 169.1% return, outperforming this stock by 213.9%
Against Peers
![]()
In the last 3 years, Vimta Labs Ltd has given 149.6% return, outperforming this stock by 218.0%
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 27.19% of holdings in Sep 2025 quarter
Price Dip
![]()
In the last 3 years, Vanta Bioscience stock has moved down by -68.4%
| Organisation | Vanta Bioscience Ltd |
| Industry | Healthcare |
| CEO | Mohan Krishna Mulakala |
| E-voting on shares | Click here to vote |
Vanta Bioscience share price today stands at ₹19.5 as on at the close of the market. Vanta Bioscience share today touched a day high of ₹19.5 and a low of ₹19.4.
Vanta Bioscience touched a 52 week high of ₹40.93 and a 52 week low of ₹16.85. Vanta Bioscience share price today i.e. is closed at ₹19.5, which is -52.36% down from its 52 week high and 15.73% up from its 52 week low.
Vanta Bioscience market capitalisation is ₹13.87 Cr as on .
To buy Vanta Bioscience shares, you need to follow these steps:
Vanta Bioscience trading volume is 6,750.00 as on . This means that 6,750.00 shares of Vanta Bioscience were bought and sold on the stock market during today's trading session.